Qbic I

Qbic I, established in 2013, is an early-stage venture capital fund based in Ghent, Belgium. It focuses on investing in software, deep tech, biotech, and medtech sectors. The fund, managed by Qbic Venture Partners, supports spin-off companies from Ghent, Brussels, and Antwerp university associations, as well as VITO. It has over €30 million under management and is backed by both public and private investors. Qbic I's investment approach involves early, in-depth analysis and subsequent hands-on involvement in portfolio companies.

Sofie Baeten

CEO

Vincent Lenders

Investment Analyst

Steven Leuridan

Partner

Cedric Van Nevel

Investment Manager

Tom Smets

Investment Analyst

57 past transactions

Aloxy

Venture Round in 2025
Aloxy specializes in providing industrial Internet of Things (IoT) solutions for monitoring manual valve positions in various process industries, including chemical, oil, and gas. The company offers a range of services such as valve position monitoring, emergency shower management, line blind management, device management, network monitoring, and data integrity. Aloxy's solutions are designed to enhance operational safety, efficiency, and sustainability by utilizing modular systems that incorporate advanced sensors. These sensors are capable of detecting environmental factors such as temperature, atmospheric pressure, vibrations, movement, inclination, rotation, and magnetic fields. By automating processes and delivering actionable insights, Aloxy aims to support its clients in optimizing their industrial operations.

Pleevi

Pre Seed Round in 2025
Pleevi specializes in optimizing electric vehicle (EV) charging for large parking facilities. It provides an AI-driven software solution that intelligently schedules charging sessions, considering local energy generation, pricing, and building load constraints. This ensures cheaper, greener charging while maintaining driver convenience, as vehicles are fully charged by the time drivers are ready to depart.

Swave Photonics

Series A in 2025
Swave Photonics specializes in the design and marketing of holographic chips utilizing proprietary diffractive photonics technology. The company aims to enhance augmented reality experiences through its innovative NanoPixel technology, which allows for the creation of compact, lightweight, and high-resolution displays. By focusing on the integration of digital content with the real world, Swave Photonics seeks to empower display manufacturers and content creators to produce immersive, ultra-high-resolution holographic displays. This approach contributes to the development of a more interactive metaverse, enabling users to visualize complex concepts, collaborate effectively, and achieve greater outcomes.

Weavely

Seed Round in 2024
Weavely is a Figma plugin that creates, customizes, and publishes AI-generated forms and surveys, after which replies are collected.

Confo Therapeutics

Series B in 2024
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

Flindr Therapeutics

Series A in 2024
Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

AmphiStar

Seed Round in 2024
AmphiStar is a biotechnology company focused on producing sophorolipid products derived from biobased waste and side streams. The company utilizes a biosurfactant technology platform that facilitates the shift from fossil-based processes to more sustainable, environmentally friendly alternatives. By employing industrial biotechnology, AmphiStar's production methods rely on renewable raw materials, including biomass feedstocks such as glucose, fatty crude glycerine, and food waste. This approach supports the healthcare industry in achieving sustainability in the production of biosurfactants, aligning with the growing demand for eco-friendly solutions.

VoxelSensors

Seed Round in 2024
VoxelSensors specializes in advanced sensing technology that enhances spatial and empathic interfaces for mobile, extended reality (XR), and industrial applications. The company's proprietary Single Photon Active Event Sensor (SPAES) technology employs Single-Photon Avalanche Diodes (SPADs) to provide low-power, low-latency solutions for spatial awareness, gaze tracking, and intuitive user interactions. This innovative system architecture is tailored to meet the needs of manufacturers in the consumer electronics sector, enabling a new category of efficient three-dimensional perception systems. VoxelSensors' technology not only supports the growth of mobile and XR markets but also addresses the increasing demand for immersive and autonomous experiences across various industries. By leveraging this groundbreaking technology, VoxelSensors aims to transform consumer electronics, smartphones, wearables, and industrial applications, ultimately blurring the lines between the physical and digital worlds.

Tanai Therapeutics

Seed Round in 2023
Tanai Therapeutics develops novel therapeutics for people living with obesity and obesity-related complications.

Swave Photonics

Seed Round in 2023
Swave Photonics specializes in the design and marketing of holographic chips utilizing proprietary diffractive photonics technology. The company aims to enhance augmented reality experiences through its innovative NanoPixel technology, which allows for the creation of compact, lightweight, and high-resolution displays. By focusing on the integration of digital content with the real world, Swave Photonics seeks to empower display manufacturers and content creators to produce immersive, ultra-high-resolution holographic displays. This approach contributes to the development of a more interactive metaverse, enabling users to visualize complex concepts, collaborate effectively, and achieve greater outcomes.

Hysopt

Seed Round in 2022
Hysopt specializes in developing and selling software designed for HVAC designers, engineering firms, installation companies, architects, builders, and manufacturers. The company’s software focuses on simulating and evaluating the performance of heating, ventilation, and air conditioning systems under various load conditions. By quantifying energy consumption, comfort levels, investment costs, and lifecycle expenses, Hysopt's tools help users identify optimal components for enhancing HVAC efficiency. The software aims to improve overall system performance, reduce carbon emissions, and lower energy costs, contributing to more sustainable building practices.

Weavely

Pre Seed Round in 2022
Weavely is a Figma plugin that creates, customizes, and publishes AI-generated forms and surveys, after which replies are collected.

Morrow Optics

Angel Round in 2022
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.

VoxelSensors

Seed Round in 2022
VoxelSensors specializes in advanced sensing technology that enhances spatial and empathic interfaces for mobile, extended reality (XR), and industrial applications. The company's proprietary Single Photon Active Event Sensor (SPAES) technology employs Single-Photon Avalanche Diodes (SPADs) to provide low-power, low-latency solutions for spatial awareness, gaze tracking, and intuitive user interactions. This innovative system architecture is tailored to meet the needs of manufacturers in the consumer electronics sector, enabling a new category of efficient three-dimensional perception systems. VoxelSensors' technology not only supports the growth of mobile and XR markets but also addresses the increasing demand for immersive and autonomous experiences across various industries. By leveraging this groundbreaking technology, VoxelSensors aims to transform consumer electronics, smartphones, wearables, and industrial applications, ultimately blurring the lines between the physical and digital worlds.

Swave Photonics

Seed Round in 2022
Swave Photonics specializes in the design and marketing of holographic chips utilizing proprietary diffractive photonics technology. The company aims to enhance augmented reality experiences through its innovative NanoPixel technology, which allows for the creation of compact, lightweight, and high-resolution displays. By focusing on the integration of digital content with the real world, Swave Photonics seeks to empower display manufacturers and content creators to produce immersive, ultra-high-resolution holographic displays. This approach contributes to the development of a more interactive metaverse, enabling users to visualize complex concepts, collaborate effectively, and achieve greater outcomes.

Aloxy

Venture Round in 2022
Aloxy specializes in providing industrial Internet of Things (IoT) solutions for monitoring manual valve positions in various process industries, including chemical, oil, and gas. The company offers a range of services such as valve position monitoring, emergency shower management, line blind management, device management, network monitoring, and data integrity. Aloxy's solutions are designed to enhance operational safety, efficiency, and sustainability by utilizing modular systems that incorporate advanced sensors. These sensors are capable of detecting environmental factors such as temperature, atmospheric pressure, vibrations, movement, inclination, rotation, and magnetic fields. By automating processes and delivering actionable insights, Aloxy aims to support its clients in optimizing their industrial operations.

EyeD Pharma

Venture Round in 2021
EyeD Pharma SA is a pharmaceutical company based in Liège, Belgium, specializing in the development and commercialization of innovative drug products for ophthalmology. The company focuses primarily on the treatment of glaucoma, a condition traditionally managed through daily eye drop administration. EyeD Pharma aims to enhance the quality of life for patients by creating therapies that reduce side effects associated with existing treatments. In collaboration with ophthalmologists, the company offers new treatment options and surgical products, helping to improve clinical practices and provide therapeutic assistance that is currently lacking in the market.

Crowd Scan

Series A in 2021
Crowd Scan offers crowd density prediction services and integrated crowd management solutions. It designs a solution for measuring and analysing crowd density in real-time using a wireless sensor network.

Trince

Seed Round in 2021
Trince is a company focused on advancing cell-based science and therapeutics through innovative cell transfection technology. It specializes in facilitating the delivery of molecules into cells, both in vitro and ex vivo. The company's platform utilizes a combination of laser exposure and photothermal nanoparticles, which convert light energy into heat to temporarily permeabilize the cellular plasma membrane. This process enables high-throughput introduction of genetic material into cells, thereby assisting clients in their research and development efforts in the field of molecular biology.

Sentea

Venture Round in 2021
Sentea specializes in fiber optic sensing technology that provides precise and reliable structural health monitoring solutions. These advanced sensors are designed to predict and prevent equipment failures and structural damage, even in challenging environments. By integrating optical components directly onto a chip, Sentea offers cost-effective sensor interrogators that enhance operational efficiency for industrial installations. The company's innovative approach facilitates the monitoring and improvement of equipment performance, ensuring greater reliability and safety in various applications.

Accelleran

Series B in 2021
Accelleran, founded in 2013 and based in Antwerp, Belgium, specializes in delivering Open RAN-aligned Private 5G networks tailored for enterprises of all sizes. The company's solutions facilitate the deployment of multi-vendor, disaggregated Private 5G networks, comparable in ease to WiFi installations. By utilizing cloud-native techniques, Accelleran's offerings provide flexibility, innovation, and scalability while ensuring hardware independence. This approach enables businesses to achieve network virtualization, enhancing their ability to serve private, public, and neutral host networks. Accelleran aims to enhance user experiences through intelligent automation and real-time network control, positioning itself as a viable alternative to traditional mobile telecom systems.

Aphea.Bio

Series B in 2021
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.

Abscint

Seed Round in 2021
ABSCINT engages in the development of radiolabelled single-domain antibodies for whole-body molecular imaging applications. Molecular imaging is used for the diagnosis of disease, the molecular characterization of a disease, monitoring treatment response, and the detection of disease recurrence.

Aphea.Bio

Series B in 2020
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.

Indigo Diabetes

Series B in 2020
Indigo Diabetes, established in 2016 and headquartered in Ghent, Belgium, specializes in developing innovative, non-invasive glucose monitoring solutions. The company's flagship product is an invisible, photonics-based sensor that is inserted under the skin, continuously measuring blood sugar levels, thereby eliminating the need for traditional finger pricks. Indigo Diabetes aims to enhance the lives of people with diabetes by providing accurate glucose monitoring with an improved user experience.

QustomDot

Seed Round in 2020
QustomDot is a company based in Ghent, Belgium, specializing in the development and manufacturing of on-chip grade and cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed to transform ultraviolet or blue light into pure colors, enhancing the image quality of various display technologies. QustomDot's products are applicable in LED/LCD televisions, smartphones, smartwatches, virtual and augmented reality goggles, and LED lighting solutions. The company not only produces quantum dots but also assists customers in integrating these advanced materials into their products, helping to improve color gamut and energy efficiency. Founded in 2020, QustomDot is focused on innovation in the field of advanced materials.

MRM Health NV

Series A in 2020
MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, that specializes in developing microbiome-based therapeutics for metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies, the company collaborates with the Flemish Institute of Biotechnology (VIB) to translate scientific research into practical applications. MRM Health is focused on innovative drug development, particularly its lead candidate MH002, aimed at treating Inflammatory Bowel Disease (IBD), which encompasses conditions such as Ulcerative Colitis and Crohn's disease. Through its research and development efforts, MRM Health seeks to advance therapeutic options based on the human microbiome.

Calltic

Series A in 2020
Calltic, founded in 2017 and located in Gent, Belgium, specializes in fraud detection services for the telecommunications industry. The company offers an innovative approach to combating telecom fraud, focusing on the rapid and accurate detection of SIM boxes through advanced pattern recognition methods. By utilizing a single tool, Calltic effectively identifies both on-net and off-net fraud, enabling its clients to significantly reduce the financial losses associated with fraudulent activities. This comprehensive solution aims to outperform traditional call detail record profiling techniques, providing a more efficient way for telecom operators to protect their revenues.

Biotalys

Series C in 2019
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Unifly

Series B in 2019
Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

EyeD Pharma

Funding Round in 2019
EyeD Pharma SA is a pharmaceutical company based in Liège, Belgium, specializing in the development and commercialization of innovative drug products for ophthalmology. The company focuses primarily on the treatment of glaucoma, a condition traditionally managed through daily eye drop administration. EyeD Pharma aims to enhance the quality of life for patients by creating therapies that reduce side effects associated with existing treatments. In collaboration with ophthalmologists, the company offers new treatment options and surgical products, helping to improve clinical practices and provide therapeutic assistance that is currently lacking in the market.

iFLUX

Venture Round in 2019
iFLUX is a company focused on sustainable groundwater management, addressing the pressing issue of water scarcity. Founded in 2017, it utilizes patented groundwater sampling technology, known as iFLUX Samplers, to monitor groundwater contamination effectively. This technology facilitates faster and more cost-efficient remediation projects by tracking groundwater and contaminant movement over time. iFLUX combines commercial sensors with unique vertical and horizontal flux sensors to create advanced real-time digital monitoring networks. These networks provide actionable insights through a personalized dashboard, allowing clients to analyze and interpret data related to groundwater dynamics. The company's solutions are designed for various sectors, including cities, conservation parks, the construction industry, and drinking water utilities, enabling them to manage complex groundwater challenges and reduce the risks associated with soil contamination. Through its innovative approach, iFLUX empowers clients to take immediate and informed actions to protect groundwater resources.

Aloxy

Series A in 2018
Aloxy specializes in providing industrial Internet of Things (IoT) solutions for monitoring manual valve positions in various process industries, including chemical, oil, and gas. The company offers a range of services such as valve position monitoring, emergency shower management, line blind management, device management, network monitoring, and data integrity. Aloxy's solutions are designed to enhance operational safety, efficiency, and sustainability by utilizing modular systems that incorporate advanced sensors. These sensors are capable of detecting environmental factors such as temperature, atmospheric pressure, vibrations, movement, inclination, rotation, and magnetic fields. By automating processes and delivering actionable insights, Aloxy aims to support its clients in optimizing their industrial operations.

Hysopt

Seed Round in 2018
Hysopt specializes in developing and selling software designed for HVAC designers, engineering firms, installation companies, architects, builders, and manufacturers. The company’s software focuses on simulating and evaluating the performance of heating, ventilation, and air conditioning systems under various load conditions. By quantifying energy consumption, comfort levels, investment costs, and lifecycle expenses, Hysopt's tools help users identify optimal components for enhancing HVAC efficiency. The software aims to improve overall system performance, reduce carbon emissions, and lower energy costs, contributing to more sustainable building practices.

Laminaria

Venture Round in 2017
Laminaria, founded in 2011 and based in Ostend, Belgium, specializes in manufacturing wave energy converter equipment. The company is at the forefront of developing technology designed to harness renewable wave energy, using a system that converts tilting and translating motions into power through mooring ropes connected to generators. Laminaria leads the LAMWEC project, a consortium of ocean energy experts that includes organizations such as EMEC, Innosea, Ghent University, and TTI Testing. Through its innovative technology, Laminaria aims to significantly impact the renewable energy landscape by advancing the effectiveness and efficiency of wave energy conversion.

Blue Foot Membranes

Seed Round in 2017
Blue Foot Membranes is a start-up company founded in 2017 in Lommel, Limburg, specializing in the production and commercialization of the Integrated Permeate Channel (IPC™) technology. This unique, patented technology is designed for use in Membrane Bioreactors, specifically aimed at the treatment of industrial and municipal wastewater. The company manufactures washable flat sheet membranes that offer enhanced fouling control, resulting in improved filtration efficiency. By enabling industries and municipalities to effectively reuse wastewater, Blue Foot Membranes contributes to more sustainable water management practices.

Sentiance

Series A in 2017
Sentiance is a data science company specializing in motion insights derived from IoT sensor data. It develops advanced technology that transforms motion data into contextual insights, enabling better understanding of individual behavior and real-time contexts. Sentiance serves various sectors, including motor insurance, ride-hailing, delivery services, automotive OEMs, and transport authorities. By employing on-device AI and behavioral change techniques, the company personalizes engagement strategies aimed at enhancing safety and sustainability in mobility. This innovative approach helps clients reduce accidents, improve claims handling, boost customer engagement and acquisition, enhance loss ratios, and implement tailored driver safety programs.

Aphea.Bio

Series A in 2017
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.

PharmaFluidics

Venture Round in 2017
PharmaFluidics is a spin-off from the Vrije Universiteit Brussel that specializes in developing innovative micro-chip-based chromatography columns for applications in biomarker detection, diagnostics, and drug research and development. The company focuses on creating integrated milli- to nano-engineered solutions tailored for mixing, separation, and reaction processes, leveraging its expertise in chemical engineering and micro-fabrication technology. By providing high-quality, custom solutions, PharmaFluidics aims to enhance the sensitivity and accuracy of detecting active compounds in complex biological samples, including biopsies and proteome digests. This approach supports researchers in their efforts to achieve more effective analytical separations, ultimately benefiting the chemical and life sciences industries.

Indigo Diabetes

Series A in 2016
Indigo Diabetes, established in 2016 and headquartered in Ghent, Belgium, specializes in developing innovative, non-invasive glucose monitoring solutions. The company's flagship product is an invisible, photonics-based sensor that is inserted under the skin, continuously measuring blood sugar levels, thereby eliminating the need for traditional finger pricks. Indigo Diabetes aims to enhance the lives of people with diabetes by providing accurate glucose monitoring with an improved user experience.

Morrow Optics

Seed Round in 2016
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.

Molecubes

Seed Round in 2016
MOLECUBES is a spin-off from Ghent University that specializes in the development of modular preclinical imaging systems designed for laboratory environments. Originating from the MEDISIP research group, the company focuses on creating versatile imaging cubes that integrate SPECT, PET, and CT technologies, allowing researchers to conduct high-performance imaging studies on small animals with minimal space requirements. These benchtop platforms are equipped with intuitive wireless acquisition and reconstruction software, making them accessible for users with varying levels of expertise. By prioritizing the needs of end-users, MOLECUBES emphasizes the significance of reliable servicing to enhance the user experience and improve daily imaging practices in preclinical research.

Smartnodes

Seed Round in 2016
SmartNodes S.A., founded in 2014 and based in Liege, Belgium, specializes in innovative lighting systems and solutions aimed at enhancing urban environments. The company's flagship product, the smart lighting system (SLS-G3), integrates various components including node units and power units, alongside systems for smart lighting control and noise monitoring. SmartNodes focuses on providing energy-efficient solutions that lower power consumption while ensuring safety and visual comfort for users. By adjusting light levels based on the presence of pedestrians and vehicles, the company effectively reduces light pollution and the ecological footprint of public lighting systems. Its offerings cater to both public authorities and the private sector, aiming to transform urban lighting through advanced technology and sustainability. As of July 2019, SmartNodes operates as a subsidiary of Lacroix SA.

Sentiance

Seed Round in 2015
Sentiance is a data science company specializing in motion insights derived from IoT sensor data. It develops advanced technology that transforms motion data into contextual insights, enabling better understanding of individual behavior and real-time contexts. Sentiance serves various sectors, including motor insurance, ride-hailing, delivery services, automotive OEMs, and transport authorities. By employing on-device AI and behavioral change techniques, the company personalizes engagement strategies aimed at enhancing safety and sustainability in mobility. This innovative approach helps clients reduce accidents, improve claims handling, boost customer engagement and acquisition, enhance loss ratios, and implement tailored driver safety programs.

Ovizio

Venture Round in 2015
Ovizio specializes in digital holographic interferometric microscopy, creating advanced 4D microscopic imaging devices and associated software. The company targets scientists and biomanufacturers by offering automated cell culture monitoring and analysis systems that enhance the scaling of cell culture processes. Its technology is primarily aimed at the life sciences sector, specifically in bioprocessing and research and development. By utilizing digital holographic microscopy, Ovizio provides innovative solutions that support the growth and efficiency of scientific operations.

Mind4Energy

Venture Round in 2015
Mind4Energy is a company founded by four engineers focused on providing high-quality services in the renewable energy sector, particularly in photovoltaic systems. The company has developed a software solution designed to monitor, analyze, and optimize the performance of solar parks. This software tracks key metrics such as capacity, currents, voltages, and overall efficiency, generating performance reports that include alarms and error messages. By utilizing this technology, customers can reduce operational costs, detect power losses, and effectively monitor large solar installations, addressing the critical challenge of ensuring a reliable and sustainable energy supply.

Unifly

Seed Round in 2015
Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

CoScale

Venture Round in 2015
CoScale offers a comprehensive performance monitoring platform tailored for production environments, focusing on servers, containers, and applications. The platform provides continuous monitoring and assesses the impact of performance on user experience and essential business metrics. By utilizing automated anomaly detection and contextual insights, CoScale enables proactive management of performance fluctuations that could affect financial outcomes. Its user base includes DevOps engineers, application owners, and business managers, all seeking to enhance digital performance through faster and more reliable websites and applications. This leads to improved user experiences and increased conversion rates, positioning CoScale as a valuable tool for organizations aiming to optimize their digital infrastructure.

Confo Therapeutics

Venture Round in 2015
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

Sentiance

Seed Round in 2015
Sentiance is a data science company specializing in motion insights derived from IoT sensor data. It develops advanced technology that transforms motion data into contextual insights, enabling better understanding of individual behavior and real-time contexts. Sentiance serves various sectors, including motor insurance, ride-hailing, delivery services, automotive OEMs, and transport authorities. By employing on-device AI and behavioral change techniques, the company personalizes engagement strategies aimed at enhancing safety and sustainability in mobility. This innovative approach helps clients reduce accidents, improve claims handling, boost customer engagement and acquisition, enhance loss ratios, and implement tailored driver safety programs.

Biogazelle

Venture Round in 2014
Biogazelle offers expert laboratory services in nucleic acid quantification (gene expression, mutation, and copy number analysis, antisense oligonucleotide screening) to support its customers in their development of diagnostics and therapeutics. Customized workflows for clinically relevant samples – from liquid biopsies to fixed tissues – are available. In addition, Biogazelle’s advanced RNA biomarker development program offers an end-to-end solution from RNA biomarker panel discovery (including liquid biopsies) to the development of a PCR-based molecular diagnostic test. Biogazelle also serves as a specialty lab in the field of clinical trials and in routine diagnostic settings.

PharmaFluidics

Venture Round in 2014
PharmaFluidics is a spin-off from the Vrije Universiteit Brussel that specializes in developing innovative micro-chip-based chromatography columns for applications in biomarker detection, diagnostics, and drug research and development. The company focuses on creating integrated milli- to nano-engineered solutions tailored for mixing, separation, and reaction processes, leveraging its expertise in chemical engineering and micro-fabrication technology. By providing high-quality, custom solutions, PharmaFluidics aims to enhance the sensitivity and accuracy of detecting active compounds in complex biological samples, including biopsies and proteome digests. This approach supports researchers in their efforts to achieve more effective analytical separations, ultimately benefiting the chemical and life sciences industries.

Track4c

Venture Round in 2014
Track4C, founded in 2012, specializes in providing end-to-end container and cargo tracking services aimed at enhancing supply chain transparency. The company delivers affordable and effective solutions by offering both hardware and software tools necessary for tracking containers or fleets. Utilizing GSM technology, Track4C enables clients to access real-time information through a web-based dashboard, facilitating seamless integration with existing ICT systems. This approach significantly reduces administrative burdens and operational costs for businesses. The company benefits from support by various business incubators and has received substantial funding from prominent venture capital firms in Belgium. Its management team possesses extensive experience in telecommunications and other diverse fields, positioning Track4C as a key player in the logistics and supply chain sector.

CoScale

Seed Round in 2014
CoScale offers a comprehensive performance monitoring platform tailored for production environments, focusing on servers, containers, and applications. The platform provides continuous monitoring and assesses the impact of performance on user experience and essential business metrics. By utilizing automated anomaly detection and contextual insights, CoScale enables proactive management of performance fluctuations that could affect financial outcomes. Its user base includes DevOps engineers, application owners, and business managers, all seeking to enhance digital performance through faster and more reliable websites and applications. This leads to improved user experiences and increased conversion rates, positioning CoScale as a valuable tool for organizations aiming to optimize their digital infrastructure.

Multiplicom

Venture Round in 2013
Multiplicom specializes in the development of molecular diagnostics products aimed at medical genetics and clinical laboratory applications. The company manufactures molecular diagnostic kits that facilitate the collection of genetic information, enabling personalized treatment options for patients. These kits are particularly valuable for early identification of congenital defects during pregnancy, thereby supporting effective and affordable healthcare solutions. Through its innovative products, Multiplicom strives to enhance access to personalized medicine in the field of genetics.

Eyeo

Eyeo is fundamentally redefining image sensing by eliminating decades-old limitations, Capturing all incoming light and drastically improving resolution.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.